These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23873027)

  • 21. Interaction of IGF signaling and the androgen receptor in prostate cancer progression.
    Wu JD; Haugk K; Woodke L; Nelson P; Coleman I; Plymate SR
    J Cell Biochem; 2006 Oct; 99(2):392-401. PubMed ID: 16639715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Androgen receptor signals regulate UDP-glucuronosyltransferases in the urinary bladder: a potential mechanism of androgen-induced bladder carcinogenesis.
    Izumi K; Zheng Y; Hsu JW; Chang C; Miyamoto H
    Mol Carcinog; 2013 Feb; 52(2):94-102. PubMed ID: 22086872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specificity of cyclin D1 for androgen receptor regulation.
    Petre-Draviam CE; Cook SL; Burd CJ; Marshall TW; Wetherill YB; Knudsen KE
    Cancer Res; 2003 Aug; 63(16):4903-13. PubMed ID: 12941814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic strategy for targeting therapy in castration-resistant prostate cancer.
    Mendiratta P; Mostaghel E; Guinney J; Tewari AK; Porrello A; Barry WT; Nelson PS; Febbo PG
    J Clin Oncol; 2009 Apr; 27(12):2022-9. PubMed ID: 19289629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer.
    Linja MJ; Savinainen KJ; Saramäki OR; Tammela TL; Vessella RL; Visakorpi T
    Cancer Res; 2001 May; 61(9):3550-5. PubMed ID: 11325816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of the androgen receptor in the development and progression of prostate cancer.
    Jenster G
    Semin Oncol; 1999 Aug; 26(4):407-21. PubMed ID: 10482183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of the transcriptional coactivator FHL2 licenses activation of the androgen receptor in castrate-resistant prostate cancer.
    McGrath MJ; Binge LC; Sriratana A; Wang H; Robinson PA; Pook D; Fedele CG; Brown S; Dyson JM; Cottle DL; Cowling BS; Niranjan B; Risbridger GP; Mitchell CA
    Cancer Res; 2013 Aug; 73(16):5066-79. PubMed ID: 23801747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor.
    Litvinov IV; Antony L; Dalrymple SL; Becker R; Cheng L; Isaacs JT
    Prostate; 2006 Sep; 66(12):1329-38. PubMed ID: 16835890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hormone treatment for prostate cancer: current issues and future directions.
    Ichikawa T; Suzuki H; Ueda T; Komiya A; Imamoto T; Kojima S
    Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():58-63. PubMed ID: 16273367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Androgen receptor (AR) expression in prostate cancer and progression of the tumor: Lessons from cell lines, animal models and human specimens.
    Tamburrino L; Salvianti F; Marchiani S; Pinzani P; Nesi G; Serni S; Forti G; Baldi E
    Steroids; 2012 Aug; 77(10):996-1001. PubMed ID: 22289337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue-specific knockout of androgen receptor in mice.
    Lin TH; Yeh S; Chang C
    Methods Mol Biol; 2011; 776():275-93. PubMed ID: 21796532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The emerging role of the androgen receptor in bladder cancer.
    Lombard AP; Mudryj M
    Endocr Relat Cancer; 2015 Oct; 22(5):R265-77. PubMed ID: 26229034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Androgen receptor (AR) physiological roles in male and female reproductive systems: lessons learned from AR-knockout mice lacking AR in selective cells.
    Chang C; Lee SO; Wang RS; Yeh S; Chang TM
    Biol Reprod; 2013 Jul; 89(1):21. PubMed ID: 23782840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The androgen receptor expression and association with patient's survival in different cancers.
    Hu C; Fang D; Xu H; Wang Q; Xia H
    Genomics; 2020 Mar; 112(2):1926-1940. PubMed ID: 31759122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Androgen receptor influences on body defense system via modulation of innate and adaptive immune systems: lessons from conditional AR knockout mice.
    Lai JJ; Lai KP; Zeng W; Chuang KH; Altuwaijri S; Chang C
    Am J Pathol; 2012 Nov; 181(5):1504-12. PubMed ID: 22959669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A and B forms of the androgen receptor are expressed in a variety of human tissues.
    Wilson CM; McPhaul MJ
    Mol Cell Endocrinol; 1996 Jun; 120(1):51-7. PubMed ID: 8809738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stranger Things: New Roles and Opportunities for Androgen Receptor in Oncology Beyond Prostate Cancer.
    Leo J; Dondossola E; Basham KJ; Wilson NR; Alhalabi O; Gao J; Kurnit KC; White MG; McQuade JL; Westin SN; Wellberg EA; Frigo DE
    Endocrinology; 2023 Apr; 164(6):. PubMed ID: 37154098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hormonal impact on tumor growth and progression.
    Reznikov A
    Exp Oncol; 2015 Sep; 37(3):162-72. PubMed ID: 26422099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enzalutamide inhibits androgen receptor-positive bladder cancer cell growth.
    Kawahara T; Ide H; Kashiwagi E; El-Shishtawy KA; Li Y; Reis LO; Zheng Y; Miyamoto H
    Urol Oncol; 2016 Oct; 34(10):432.e15-23. PubMed ID: 27330033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.